A carregar...
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension
INTRODUCTION: Currently available endothelin receptor antagonists for treating pulmonary arterial hypertension block either the endothelin (ET) receptor A or both A and B receptors. Transition from one endothelin receptor antagonist to another may theoretically alter side-effects or efficacy. We rep...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3064451/ https://ncbi.nlm.nih.gov/pubmed/21468170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S15026 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|